Skip to main content

Table 1 Pretherapeutic patients’ characteristics

From: Association of angiogenic factors with prognosis in esophageal cancer

Characteristics

 

n

%

Median survival (IQR)

95%CI

3-Y-S (%)

p value

Total, n

 

78

100,0%

28,5 (13,7;*)

 

42,7%

 

Age (years)

63 ± 7,8 (41–80)

      

Sex

Male

62

79,5%

28,5 (13,8;*)

16,1 - 40,9

42,6%

0,711

 

Female

16

20,5%

29,1 (11,6;*)

-

45,6%

 

Localisation

AEG I/II

44

56,4%

28,5 (17,0;*)

19,2 - 37,8

37,7%

0,904

 

SCC

34

43,6%

n.r.

-

50,9%

 

cT Category

cT1

0

     
 

cT2

5

6,4%

n.r.

-

60,0%

0,812

 

cT3

69

88,5%

23,8 (12,8;*)

15,9 - 31,7

42,8%

 
 

cT4

4

5,1%

36,7 (33,7;*)

31,9 - 41,5

33,3%

 

cN Category

cN0

17

21,8%

30,6 (20,5;*)

15,5 - 45,7

37,8%

0,906

 

cN+

61

78,2%

24,0 (12,3;*)

9,1 - 38,8

44,6%

 

cM Category

cM0

67

85,9%

23,8 (12,8;*)

15,1 - 32,5

40,2%

0,317

 

cM1

11

14,1%

n.r.

-

57,3%

 

Grading

G 1/2

32

41,0%

23,1 (11,0;*)

13,4 - 32,7

34,0%

0,428

 

G 3/4

38

48,7%

29,1 (13,8;*)

-

45,5%

 

Lauren initial (AEG)

Intestinal

26

59,1%

30,6 (17,0;*)

15,6 - 45,6

40,4%

0,620

 

Nonintestinal

13

29,5%

24,0 (20,3;*)

19,3 - 28,6

33,8%

 
  1. Median Survival shown in months; n.r.: not reached; CI: confidence interval; 3-Y-S: 3-Year-Survival; IQR: inter quartile range (1st quartile; 3rd quartile (* 3rd quartile not reached)).